<p>Prestige Consumer Healthcare（紐約證券交易所代碼：PBH - 獲取免費報告）於週四發佈了季度財報。該公司報告季度每股收益為 1.07 美元，超出分析師一致預期的 0.97 美元，超出幅度為 0.10 美元，Zacks 報道。Prestige Consumer Healthcare 的股本回報率為 12.69%，淨利潤率為 19.02%。該季度的營業收入為 2.7411 億美元，而一致預期為 2.5714 億美元。在去年同期，該公司每股收益為 1.09 美元。該季度的營業收入同比下降了 3.4%。Prestige Consumer Healthcare 更新了其 2026 財年的指引，預計每股收益為 4.540-4.580 美元。</p>
<h2>Prestige Consumer Healthcare 股價下跌 2.5%</h2>
<p>週五交易時段，PBH 股價下跌 1.51 美元，達到 59.85 美元。該股票交易量為 578,048 股，而其平均交易量為 417,609 股。Prestige Consumer Healthcare 的 52 周低點為 59.51 美元，52 周高點為 90.04 美元。該公司的市值為 29.5 億美元，市盈率為 14.05，PEG 比率為 1.93，貝塔值為 0.41。該公司的債務與股本比率為 0.55，流動比率為 4.38，速動比率為 2.99。該公司的 50 日簡單移動平均線為 62.98 美元，200 日簡單移動平均線為 73.18 美元。</p>
<h2>Prestige Consumer Healthcare 的機構交易</h2>
<p>大型投資者最近調整了對該公司的持股。美國銀行（Bank of America Corp DE）在第二季度將其在 Prestige Consumer Healthcare 的持股增加了 19.1%。美國銀行目前擁有 721,371 股該公司的股票，價值 57,601,000 美元，此前在該期間購買了 115,459 股。製造商人壽保險公司（The Manufacturers Life Insurance Company）在第二季度將其在 Prestige Consumer Healthcare 的持股增加了 12.9%。製造商人壽保險公司目前擁有 553,407 股該公司的股票，價值 44,190,000 美元，此前在上個季度購買了 63,168 股。高盛集團（Goldman Sachs Group Inc.）在第一季度將其在 Prestige Consumer Healthcare 的持股增加了 28.4%。高盛集團目前擁有 546,672 股該公司的股票，價值 46,997,000 美元，此前在上個季度購買了 120,965 股。公共部門養老金投資委員會（Public Sector Pension Investment Board）在第二季度將其在 Prestige Consumer Healthcare 的持股增加了 6.2%。公共部門養老金投資委員會目前擁有 189,134 股該公司的股票，價值 15,102,000 美元，此前在該期間購買了 11,115 股。最後，Jane Street Group LLC 在第二季度將其在 Prestige Consumer Healthcare 的持股增加了 25.3%。Jane Street Group LLC 目前擁有 131,337 股該公司的股票，價值 10,487,000 美元，此前在上個季度購買了 26,535 股。目前 99.95% 的股票由機構投資者和對沖基金持有。</p>
<h2>分析師的升級和降級</h2>
<p>幾位股票研究分析師對 PBH 股票發表了評論。傑富瑞金融集團（Jefferies Financial Group）在 10 月 27 日的研究報告中將 Prestige Consumer Healthcare 的目標價從 75.00 美元下調至 71.00 美元，並對該公司給予 “持有” 評級。華爾街 Zen 在 8 月 9 日的報告中將 Prestige Consumer Healthcare 的評級從 “買入” 下調至 “持有”。奧本海默（Oppenheimer）在 10 月 21 日的研究報告中將 Prestige Consumer Healthcare 的目標價從 82.00 美元下調至 72.00 美元，並對該公司給予 “跑贏大盤” 評級。Weiss Ratings 在 10 月 8 日的研究報告中重申了對 Prestige Consumer Healthcare 的 “持有（c）” 評級。最後，加拿大皇家銀行（Canaccord Genuity Group）在週五的研究報告中將 Prestige Consumer Healthcare 的目標價從 100.00 美元下調至 88.00 美元，並對該公司給予 “買入” 評級。四位股票研究分析師對該股票給予 “買入” 評級，三位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，該公司的共識評級為 “持有”，共識目標價為 85.33 美元。</p>
<p><strong>查看我們對 Prestige Consumer Healthcare 的最新分析</strong></p>
<h2>關於 Prestige Consumer Healthcare</h2>
<p>（獲取免費報告）</p>
<p>Prestige Consumer Healthcare Inc 及其子公司在美國和國際上開發、製造、營銷、分銷和銷售非處方（OTC）健康和個人護理產品。該公司分為兩個部門，北美 OTC 醫療保健和國際 OTC 醫療保健。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Prestige Consumer Healthcare</li>
<li>REIT 股票 - 今天值得加入您投資組合的最佳 REIT 股票</li>
<li>Rivian 的圖表顯示可以買入，但一些分析師仍然持否定態度</li>
<li>想在下跌趨勢中獲利？下跌趨勢解析。</li>
<li>e.l.f.的拋售是購買的好時機，分析師表示</li>
<li>醫療保健股票解析：為什麼您可能想要投資</li>
<li>T-Mobile 是最被低估的巨型股票——現在是買入時機嗎？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBCSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBCSA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>您現在應該投資 1,000 美元在 Prestige Consumer Healthcare 嗎？</h2>
<p>在您考慮 Prestige Consumer Healthcare 之前，您需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Prestige Consumer Healthcare 並不在名單上。</p>
<p>雖然普雷斯蒂奇消費醫療目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

普雷斯蒂奇

<p>Prestige Consumer Healthcare（紐約證券交易所代碼：PBH）報告的季度每股收益為 1.07 美元，超出預期 0.10 美元。收入為 2.7411 億美元，超過預期的 2.5714 億美元，但同比下降 3.4%。公司更新了 2026 財年的指引，預計每股收益在 4.540-4.580 美元之間。儘管盈利表現積極，PBH 的股價仍下跌 2.5%，至 59.85 美元。機構投資者持有 99.95% 的股份，主要公司近期對持股進行了調整。分析師的評級意見不一，普遍評級為 “持有”，目標價為 85.33 美元</p>

<p>Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) released its quarterly earnings data on Thursday. The company reported $1.07 EPS for the quarter, topping analysts' consensus estimates of $0.97 by $0.10, Zacks reports. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The business had revenue of $274.11 million during the quarter, compared to the consensus estimate of $257.14 million. During the same period in the prior year, the firm posted $1.09 EPS. The business's revenue for the quarter was down 3.4% on a year-over-year basis. Prestige Consumer Healthcare updated its FY 2026 guidance to 4.540-4.580 EPS.</p>
<div class="lb-trans"><p>Prestige Consumer Healthcare（紐約證券交易所代碼：PBH - 獲取免費報告）於週四發佈了季度財報。該公司報告季度每股收益為 1.07 美元，超出分析師一致預期的 0.97 美元，超出幅度為 0.10 美元，Zacks 報道。Prestige Consumer Healthcare 的股本回報率為 12.69%，淨利潤率為 19.02%。該季度的營業收入為 2.7411 億美元，而一致預期為 2.5714 億美元。在去年同期，該公司每股收益為 1.09 美元。該季度的營業收入同比下降了 3.4%。Prestige Consumer Healthcare 更新了其 2026 財年的指引，預計每股收益為 4.540-4.580 美元。</p>
</div><h2>Prestige Consumer Healthcare Stock Down 2.5%</h2>
<div class="lb-trans"><h2>Prestige Consumer Healthcare 股價下跌 2.5%</h2>
</div><p>PBH traded down $1.51 during trading hours on Friday, reaching $59.85. 578,048 shares of the stock traded hands, compared to its average volume of 417,609. Prestige Consumer Healthcare has a fifty-two week low of $59.51 and a fifty-two week high of $90.04. The company has a market cap of $2.95 billion, a price-to-earnings ratio of 14.05, a PEG ratio of 1.93 and a beta of 0.41. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99. The firm's fifty day simple moving average is $62.98 and its two-hundred day simple moving average is $73.18.</p>
<div class="lb-trans"><p>週五交易時段，PBH 股價下跌 1.51 美元，達到 59.85 美元。該股票交易量為 578,048 股，而其平均交易量為 417,609 股。Prestige Consumer Healthcare 的 52 周低點為 59.51 美元，52 周高點為 90.04 美元。該公司的市值為 29.5 億美元，市盈率為 14.05，PEG 比率為 1.93，貝塔值為 0.41。該公司的債務與股本比率為 0.55，流動比率為 4.38，速動比率為 2.99。該公司的 50 日簡單移動平均線為 62.98 美元，200 日簡單移動平均線為 73.18 美元。</p>
</div><h2>Institutional Trading of Prestige Consumer Healthcare</h2>
<div class="lb-trans"><h2>Prestige Consumer Healthcare 的機構交易</h2>
</div><p>Large investors have recently modified their holdings of the business. Bank of America Corp DE raised its holdings in shares of Prestige Consumer Healthcare by 19.1% during the second quarter. Bank of America Corp DE now owns 721,371 shares of the company's stock worth $57,601,000 after purchasing an additional 115,459 shares during the period. The Manufacturers Life Insurance Company grew its position in shares of Prestige Consumer Healthcare by 12.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 553,407 shares of the company's stock valued at $44,190,000 after buying an additional 63,168 shares during the last quarter. Goldman Sachs Group Inc. grew its position in shares of Prestige Consumer Healthcare by 28.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 546,672 shares of the company's stock valued at $46,997,000 after buying an additional 120,965 shares during the last quarter. Public Sector Pension Investment Board raised its stake in Prestige Consumer Healthcare by 6.2% during the second quarter. Public Sector Pension Investment Board now owns 189,134 shares of the company's stock worth $15,102,000 after acquiring an additional 11,115 shares during the period. Finally, Jane Street Group LLC lifted its holdings in Prestige Consumer Healthcare by 25.3% in the second quarter. Jane Street Group LLC now owns 131,337 shares of the company's stock worth $10,487,000 after acquiring an additional 26,535 shares during the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>大型投資者最近調整了對該公司的持股。美國銀行（Bank of America Corp DE）在第二季度將其在 Prestige Consumer Healthcare 的持股增加了 19.1%。美國銀行目前擁有 721,371 股該公司的股票，價值 57,601,000 美元，此前在該期間購買了 115,459 股。製造商人壽保險公司（The Manufacturers Life Insurance Company）在第二季度將其在 Prestige Consumer Healthcare 的持股增加了 12.9%。製造商人壽保險公司目前擁有 553,407 股該公司的股票，價值 44,190,000 美元，此前在上個季度購買了 63,168 股。高盛集團（Goldman Sachs Group Inc.）在第一季度將其在 Prestige Consumer Healthcare 的持股增加了 28.4%。高盛集團目前擁有 546,672 股該公司的股票，價值 46,997,000 美元，此前在上個季度購買了 120,965 股。公共部門養老金投資委員會（Public Sector Pension Investment Board）在第二季度將其在 Prestige Consumer Healthcare 的持股增加了 6.2%。公共部門養老金投資委員會目前擁有 189,134 股該公司的股票，價值 15,102,000 美元，此前在該期間購買了 11,115 股。最後，Jane Street Group LLC 在第二季度將其在 Prestige Consumer Healthcare 的持股增加了 25.3%。Jane Street Group LLC 目前擁有 131,337 股該公司的股票，價值 10,487,000 美元，此前在上個季度購買了 26,535 股。目前 99.95% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師的升級和降級</h2>
</div><p>Several equities research analysts have commented on PBH shares. Jefferies Financial Group dropped their price target on Prestige Consumer Healthcare from $75.00 to $71.00 and set a &#34;hold&#34; rating for the company in a research note on Monday, October 27th. Wall Street Zen cut Prestige Consumer Healthcare from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday, August 9th. Oppenheimer dropped their target price on shares of Prestige Consumer Healthcare from $82.00 to $72.00 and set an &#34;outperform&#34; rating for the company in a research report on Tuesday, October 21st. Weiss Ratings reaffirmed a &#34;hold (c)&#34; rating on shares of Prestige Consumer Healthcare in a research report on Wednesday, October 8th. Finally, Canaccord Genuity Group decreased their price objective on shares of Prestige Consumer Healthcare from $100.00 to $88.00 and set a &#34;buy&#34; rating for the company in a research note on Friday. Four equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of &#34;Hold&#34; and a consensus price target of $85.33.</p>
<div class="lb-trans"><p>幾位股票研究分析師對 PBH 股票發表了評論。傑富瑞金融集團（Jefferies Financial Group）在 10 月 27 日的研究報告中將 Prestige Consumer Healthcare 的目標價從 75.00 美元下調至 71.00 美元，並對該公司給予 “持有” 評級。華爾街 Zen 在 8 月 9 日的報告中將 Prestige Consumer Healthcare 的評級從 “買入” 下調至 “持有”。奧本海默（Oppenheimer）在 10 月 21 日的研究報告中將 Prestige Consumer Healthcare 的目標價從 82.00 美元下調至 72.00 美元，並對該公司給予 “跑贏大盤” 評級。Weiss Ratings 在 10 月 8 日的研究報告中重申了對 Prestige Consumer Healthcare 的 “持有（c）” 評級。最後，加拿大皇家銀行（Canaccord Genuity Group）在週五的研究報告中將 Prestige Consumer Healthcare 的目標價從 100.00 美元下調至 88.00 美元，並對該公司給予 “買入” 評級。四位股票研究分析師對該股票給予 “買入” 評級，三位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，該公司的共識評級為 “持有”，共識目標價為 85.33 美元。</p>
</div><p><strong>View Our Latest Analysis on Prestige Consumer Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我們對 Prestige Consumer Healthcare 的最新分析</strong></p>
</div><h2>About Prestige Consumer Healthcare</h2>
<div class="lb-trans"><h2>關於 Prestige Consumer Healthcare</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.</p>
<div class="lb-trans"><p>Prestige Consumer Healthcare Inc 及其子公司在美國和國際上開發、製造、營銷、分銷和銷售非處方（OTC）健康和個人護理產品。該公司分為兩個部門，北美 OTC 醫療保健和國際 OTC 醫療保健。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Prestige Consumer Healthcare</li>
<li>REIT Stocks - Best REIT Stocks to Add to Your Portfolio Today</li>
<li>Rivian’s Chart Says Go, But Some Analysts Still Say No</li>
<li>Want to Profit on the Downtrend? Downtrends, Explained.</li>
<li>e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts</li>
<li>Health Care Stocks Explained: Why You Might Want to Invest</li>
<li>T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Prestige Consumer Healthcare</li>
<li>REIT 股票 - 今天值得加入您投資組合的最佳 REIT 股票</li>
<li>Rivian 的圖表顯示可以買入，但一些分析師仍然持否定態度</li>
<li>想在下跌趨勢中獲利？下跌趨勢解析。</li>
<li>e.l.f.的拋售是購買的好時機，分析師表示</li>
<li>醫療保健股票解析：為什麼您可能想要投資</li>
<li>T-Mobile 是最被低估的巨型股票——現在是買入時機嗎？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBCSA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NYSE&amp;Symbol=PBH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Prestige Consumer Healthcare Right Now?</h2>
<div class="lb-trans"><h2>您現在應該投資 1,000 美元在 Prestige Consumer Healthcare 嗎？</h2>
</div><p>Before you consider Prestige Consumer Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考慮 Prestige Consumer Healthcare 之前，您需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prestige Consumer Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Prestige Consumer Healthcare 並不在名單上。</p>
</div><p>While Prestige Consumer Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然普雷斯蒂奇消費醫療目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

普雷斯蒂奇消費保健品公司（NYSE:PBH）公佈季度財報，每股收益超出預期 0.10 美元